Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2491-18-1 | MDL No. : | MFCD00012491 |
Formula : | C6H14ClNO2S | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MEVUPUNLVKELNV-JEDNCBNOSA-N |
M.W : | 199.70 | Pubchem ID : | 11435579 |
Synonyms : |
L-Methionine methyl ester hydrochloride
|
Chemical Name : | (S)-Methyl 2-amino-4-(methylthio)butanoate hydrochloride |
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.83 |
Num. rotatable bonds : | 5 |
Num. H-bond acceptors : | 3.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 49.5 |
TPSA : | 77.62 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.77 cm/s |
Log Po/w (iLOGP) : | 0.0 |
Log Po/w (XLOGP3) : | 1.05 |
Log Po/w (WLOGP) : | 1.04 |
Log Po/w (MLOGP) : | 0.75 |
Log Po/w (SILICOS-IT) : | 0.37 |
Consensus Log Po/w : | 0.64 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.41 |
Solubility : | 7.78 mg/ml ; 0.0389 mol/l |
Class : | Very soluble |
Log S (Ali) : | -2.27 |
Solubility : | 1.07 mg/ml ; 0.00536 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -0.94 |
Solubility : | 22.7 mg/ml ; 0.114 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.64 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
94% | at 20℃; Cooling with ice | In a typical reaction, 73 mL of acetic anhydride (780 mmol) and 63 mL pyridine (780 mmol) were combined in a round-bottomed flask and chilled on ice. After 5-10 min, 8.6 g (100 mmol) l-methionine methyl ester HCl were added and the reaction mixture was allowed to slowly return to room temperature overnight. The next morning, the reaction was quenched with cold water and extracted four times with 75 mL of methylene chloride. The extracts were then rinsed three times each with 1 M HCl, saturated sodium bicarbonate solution, and water. The extracts were then dried over MgSO4, filtered, and evaporated under reduced pressure, yielding a yellow oil which crystallized upon standing. The crude product was recrystallized in ethyl ether at -20 °C. Crystals (19.3 g, 94 mmol, 94percent) were isolated by vacuum filtration. Mp = 41.7-42.4 °C. 1H NMR ([2H]-chloroform, TMS = 0.0 ppm): δ 1.86-2.20 (m, 2H), δ 2.00 (s, 3H), δ 2.05 (s, 3H), δ 2.45-2.60 (m, 2H), δ 3.75 (s, 3H), δ 4.62-4.70 (m, 1H), δ 6.13-6.19 (bd, 1H). |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
98% | at 0℃; for 16 h; Inert atmosphere; Reflux | Synthesis Example 1 \\ ,L-Methionine (0.5g, 1 equivalent) was suspended in methanol (30ml C = 0.1M) in a 100ml flask equipped with a magnetic stirrer and placed under nitrogen. Thionyl chloride (0.5ml, 2 equivalents) was added to the solution dropwise at 0°C then heated under reflux for 16 hours. The reaction mixture was then evaporated to yield a pale yellow solid. The solid was triturated with hot diethyl ether and the solution discarded to leave the title compound 2 as a white solid which was further dried under vacuum. (0.65561 g, 98percent yield).1H NMR (D20, 500MHz) δΗ: 4.24(1 H, m, 3) 3.79(3H, s, 1), 2.63(2H, t, 5), 2.25(1 H, m, 4), 2.16(1H, m, 4), 2.06(1H, s, 6)13C NMR( D20, 125MHz) 6C: 170.58 (2), 53.64(1), 51.70(3), 28.71(4), 28.41(5), 13.85(6).IR (neat, vmax, cnV1): 2880.8/2676,2 (CH3, CH2, CH), 2016.2, 1742.2 (C=0, ester), 1483.6, 1443.5, 1227 + 1194.7 + 1149.8 + 1079.5 (C-O).HRMS m/z (+ESI): C6Hi4N02S, mass found = 64.074 (Error = 0.07ppm) |
98% | at 0℃; for 16 h; Inert atmosphere; Reflux | L-Methionine (0.5 g, 1 equivalent) was suspended in methanol (30 ml C=0.1M) in a 100 ml flask equipped with a magnetic stirrer and placed under nitrogen. Thionyl chloride (0.5 ml, 2 equivalents) was added to the solution dropwise at 0° C. then heated under reflux for 16 hours. The reaction mixture was then evaporated to yield a pale yellow solid. The solid was triturated with hot diethyl ether and the solution discarded to leave the title compound 2′ a white solid which was further dried under vacuum. (0.65561 g, 98percent yield). [0377] 1H NMR (D2O, 500 MHz) δH: 4.24 (1H, m, 3) 3.79 (3H, s, 1), 2.63 (2H, t, 5), 2.25 (1H, m, 4), 2.16 (1H, m, 4), 2.06 (1H, s, 6) [0378] 13C NMR (D2O, 125 MHz) δc: 170.58 (2), 53.64 (1), 51.70 (3), 28.71 (4), 28.41 (5), 13.85 (6). [0379] IR (neat, vmax, cm−1): 2880.8/2676.2 (CH3, CH2, CH), 2016.2, 1742.2 (C═O, ester), 1483.6, 1443.5, 1227+1194.7+1149.8+1079.5 (C—O). [0380] HRMS m/z (+ESI): C6H14NO2S, mass found=164.074 (Error=0.071 ppm) |
89% | at 20℃; for 24 h; Inert atmosphere; Reflux | Using the general methyl esterification conditions, L-methionine (8, 2.00 g, 13.4 mmol) was treated with thionyl chloride (2.00 mL, 26.8 mmol) in methanol(20 mL) to afford the title compound as a white powder (1.95 g, 89percent); νmax (KBr pellet): 3080 (s), 1747(s), 2840 (w), 1236 (s); δH (300 MHz, CDCl3): 2.28 (3H, s), 2.28–2.33 (2H, m), 2.67–2.77 (2H, m), 3.87(3H, s), 4.16–4.30 (1H, m); δC (75.4 MHz, CD3OD): 15.4, 30.5, 31.1, 53.2, 54.2, 171.2; m/z (ES+): 164 (100percent, [M+H]+). Data in agreement with literature [62]. |
67% | at 20℃; Cooling with ice | General procedure: This compound has previously been described5 and can be purchased from Toronto Research. To a round bottom flask containing MeOH (50 mL) and cooled in an ice bath was added SOCl2 (6.1 mL, 84 mmol) dropwise over 5 min. L-Leucine 1e (5.0 g, 38) was then added and the mixture was left to stir overnight at rt. The reaction mixture was concentrated on the rotovap using MeOH (2 x 50 mL) to chase away excess thionyl chloride. Diethyl ether (50 mL) was added to the resulting solids and followed by a combination of scratching and sonication to produce a white solid which was filtered, rinsing with diethyl ether (3 x 10 mL). Product was further purified by recrystallization by partially dissolving solids in hot EtOAc (50 mL) followed by cooling to rt and filtration. Yield: 3.9 g (56percent). [α]D24 +18.8° (c 0.50, MeOH). >98percent pure by NMR. 1H NMR ((CD3)2SO) δ 8.61 (br s, 3H), 3.95 (t, J = 7, 1H), 3.74 (s, 3H), 1.75 (m, 1H), 1.65 (m, 2H), 0.89 (d, J = 7, 6H). |
[ 59-51-8 ]
2-Amino-4-(methylthio)butanoic acid
Similarity: 0.83
[ 348-67-4 ]
(R)-2-Amino-4-(methylthio)butanoic acid
Similarity: 0.83
[ 63-68-3 ]
(S)-2-Amino-4-(methylthio)butanoic acid
Similarity: 0.83